Update on EpiPen® Availability
Thu, Apr 04, 2019
Update from Pfizer Canada:
The EpiPen Autojectors (0.3 MG and 0.15 MG) are now fully available (as of March 4, 2019) according to a recent communication sent out by the company.
Important Safety Information on EpiPen® and EpiPen Jr® auto-injectors: A very small number of EpiPen® and EpiPen Jr® auto-injectors may stick in their carrier tube, delaying or potentially preventing emergency treatment. Consumers need to check their device now to confirm that it can be removed from the carrier tube with ease. Click here for the full update
Recent updates from Health Canada and the Health Minister of Canada:
News Release – Health Minister announces access to a U.S.-approved epinephrine auto-injector
Interim Order Respecting Epinephrine Auto-Injectors
Explanatory Note: Epinephrine
Dear Healthcare Professional Letter
Patient Information — Auvi-Q® (epinephrine injection) Auto-Injector For Allergic Emergencies (Anaphylaxis)
Pfizer Canada does not expect to be able to provide new supply until the end of August.
The company has also advised that, at this time, they continue to be able to supply EpiPen Jr (0.15 mg)®; however, the supply is limited and is being carefully managed at the national level.
- During the shortage, and given the likelihood that quantities are expected to deplete across all pharmacies, pharmacists are encouraged to only process one EpiPen® per patient (where possible), effective immediately, to preserve supply in order to provide care to as many patients as possible until the product becomes available.
- EpiPen® products expire on the last day of the month indicated on the product packaging. For example, if the product is marked as expiring in August/2018, it remains valid (not expired) until August 31, 2018.
- Health Canada recommends that in this shortage situation if an individual is experiencing an anaphylactic reaction and has only an expired auto-injector immediately available, they should use the expired product and immediately contact 911. Regardless of whether the product is expired, as usual, a patient should get to the nearest hospital as soon as possible following the administration of the product.
- If pharmacies or patients do not have access to any form of EpiPen®, manual injection of epinephrine is an option. PAS worked together with medSask to create a supportive document on how to create an "epinephrine kit" and how to teach patients to administer a manual injection of epinephrine. Also, medSask created a video that can be used as a support for pharmacists and patients in the teaching process. PAS highly recommends that all pharmacists become familiar with kit contents and how to administer manual epinephrine.
- Pharmacists can reference the "Anaphylaxis Protocol" document on the PAS website, under the Influenza Immunization Program (and other injectables) area for information on dosing and other anaphylaxis protocol.
- There is a bulletin developed with input from Health Canada, Pfizer and pharmacy stakeholders which includes additional information and FAQs on the shortage.
If you have any questions or require additional support in managing an Epipen® shortage, please contact email@example.com.Return to list
Invitation to Participate in a Pharmacy Survey
STUDY TITLE: What are the issues affecting the supply of medicines into and within Canada, Spain and Australia – a multi-case analysis of medicines availability challenges and opportunities.More
Open Letter from NAPRA to Health Canada regarding US importation of drugs from Canada
The National Association of Pharmacy Regulatory Authorities (NAPRA) issued a letter to Health Canada expressing its concerns regarding the recent policy decision by the US government to allow importation of drugs from CanadaMore
2019‐2020 Seasonal Influenza Immunization Program Participation
The Drug Plan and Extended Benefits Branch (DPEBB) is registering pharmacies that plan to participate in the Province’s 2019‐2020 Seasonal Influenza Immunization Program (the Program).More
Florinef Shortage Update
The Florinef shortage information is posted on behalf of medSask.More